Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital, United States
Disclosure information not submitted.
A scalable approach to assess the safety of novel systemic treatments for atopic dermatitis in clinical practice: First analysis cycle of the ADVANCES sequential monitoring system
Monday, August 26, 20241:45 PM – 2:00 PM CEST
